Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
3
×
national blog main
abaloparatide
akero therapeutics
amarin
amgen
apellis pharmaceuticals
aragon pharmaceuticals
attack
boston
boston blog main
cardiovascular
cholesterol
clinical trials
corey goodman
david maron
diabetes
eicosapentaenoic acid
europe blog main
europe top stories
european commission
fda
financing
fish oil
funding
harmony biosciences
heart disease
investment
john thero
ldl
lovaza
m&a
mineral oil
national
national top stories
new york
new york blog main
new york top stories
omacor
What
risk
3
×
medicine
abuzz
ago
amarin
amgen
amgen’s
approach
approval
bags
big
biotechs
capital
carries
clinical
community
deeper
developed
dive
doctors
drug
eager
europe
european
fish
gives
heart
investing
investors
led
limited
making
marketing
medical
mitigated
months
new
nod
oil
osteoporosis
Language
unset
Current search:
risk
×
biotech
×
" life sciences "
×
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder